Accordingly,
if high-level athletes are known to be susceptible to markers
of CVD, establishing the prevalence of such markers within
athletic populations is essential in order to formulate and
evaluate strategies that may reduce mortality and morbidity
in high risk individuals, and also assist athletes or those at low
risk to maintain a life-long healthy cardiovascular state.